05-AUG-2025- Inter alia, approved:- 1. Recommended a Final Dividend of 15% i.e ` 1.50 per equity share on the face value of ` 10 each for the financial year ended March 31, 2025, subject to the approval of the shareholders in the ensuing 36th Annual General Meeting ( AGM ) of the Company. The dividend, if approved by the members, will be paid within 30 days of declaration at the ensuing 36th AGM. The record date for the purpose of determining the entitlement of dividend for the AGM to be held for the financial year ended March 31, 2025 will be July 29, 2025. 2. Approved convening of 36th AGM on Tuesday, August 5, 2025 through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). 3. Approved book closure of the Company from July 30, 2025 to August 5, 2025 (both days inclusive) for the purpose of 36th AGM. The cut-off date is July 29, 2025. The record date for the purpose of determining the entitlement of dividend for the AGM to be held for the financial year ended March 31, 2025 will be July 29, 2025. 4. Based on the recommendation of the Audit Committee, approved the appointment of Mr. Ashok Kumar Daga, Company Secretary in Practice, having Certificate of Practice No F2948 of the ICSI and Peer Review Certificate No. 1550/2021, as the Secretarial Auditors of the Company for a term of 5 (five) consecutive years commencing from the financial year 2025-26 till the financial year 2029-30, subject to approval of the shareholders of the Company at the ensuing 36th AGM of the Company 5. Based on the recommendation of Nomination and Remuneration Committee, the Board recommended the continuation of the directorship of Mr. Kashi Prasad Khandelwal as a Non-Executive Independent Director of the Company even after attainment of 75 years of age on March 4, 2026 subject to approval of the Shareholders of the Company at the ensuing 36th AGM of the Company. 6. Approved variation in terms of reappointment of Mr. Dwarika Prasad Tantia, Executive Chairman and Mr. Anurag Tantia, Executive Director, based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the Shareholders in the ensuing 36th AGM. 7. Approved payment of Doctor Consultancy Fees to Dr. Aruna Tantia, Non-Executive Non-Independent Director of the Company, based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the Shareholders in the ensuing 36th AGM. 8. In pursuance of Regulation 17(6)(ca) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") approved payment of Doctor Consultancy Fees to Dr. Ghanshyam Goyal, Non-Executive Non Independent Director of the Company for FY 2025-26 based on the recommendation of the Nomination and Remuneration Committee and Audit Committee subject to approval of Shareholders in the ensuing 36th AGM of the Company. 9. Approved the reappointment of S.K. Sahu & Associates as the Cost Auditors of the Company for Financial Year 2025-26, subject to ratification of their remuneration by the Shareholders of the Company at the ensuing 36th AGM of the Company; 10. Based on the recommendation of Audit Committee, the Board approved the appointment of RSM Astute Consulting Private Limited, Chartered Accountants, alongwith reappointment of ARVS & Associates, Chartered Accountants as Internal Auditors of the Company for the FY 2025-26. 11. Since the provision of Regulation 21(5) of LODR is not applicable to the company, accordingly the Board has dissolved Risk Management Committee with immediate effect.
Note: